PE20090824A1 - Proceso para la preparacion de trifluoralquil-fenil sulfonamidas y de sulfonamidas heterociclicas - Google Patents
Proceso para la preparacion de trifluoralquil-fenil sulfonamidas y de sulfonamidas heterociclicasInfo
- Publication number
- PE20090824A1 PE20090824A1 PE2008001177A PE2008001177A PE20090824A1 PE 20090824 A1 PE20090824 A1 PE 20090824A1 PE 2008001177 A PE2008001177 A PE 2008001177A PE 2008001177 A PE2008001177 A PE 2008001177A PE 20090824 A1 PE20090824 A1 PE 20090824A1
- Authority
- PE
- Peru
- Prior art keywords
- sulfonamides
- phenyl
- reacting
- convert
- reduce
- Prior art date
Links
- 229940124530 sulfonamide Drugs 0.000 title abstract 3
- 150000003456 sulfonamides Chemical class 0.000 title 1
- -1 SULFONAMIDE COMPOUND Chemical class 0.000 abstract 5
- 150000008064 anhydrides Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- OYSRXGQDYWTBQU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br.CC1=CC(Cl)=CC=C1OCC(O)=O OYSRXGQDYWTBQU-UHFFFAOYSA-N 0.000 abstract 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 abstract 1
- 150000001540 azides Chemical class 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 abstract 1
- XUYJLQHKOGNDPB-UHFFFAOYSA-N phosphonoacetic acid Chemical compound OC(=O)CP(O)(O)=O XUYJLQHKOGNDPB-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
REFERIDA A UN METODO DE PREPARACION DE UN COMPUESTO DE SULFONAMIDA DE FORMULA (I), DONDE R1 ES ALQUILO C1-C10, CICLOALQUILO C3-C8, ENTRE OTROS; R2 ES ARILO C6-C14, HETEROARILO DE 5 A 14 MIEMBROS, ENTRE OTROS; DONDE DICHO METODO CONSISTE EN HACER REACCIONAR N-TRIFLURACETILMORFOLINA CON R1MgX O R1Li PARA FORMAR R1C(O)CF3, DONDE X ES Br, Cl O I; CONDENSAR R1C(O)CF3 CON UN REACTIVO DE FOSFONOACETATO PARA FORMAR EtO2C-CH=C(R1)(CF3); HIDROLIZAR PARA FORMAR R1C(CF3)=CHCO2H Y CONVERTIRLO EN UN ANHIDRIDO MIXTO; HACER REACCIONAR DICHO ANHIDRIDO CON UN COMPUESTO AUXILIAR QUIRAL TAL COMO UNA OXAZOLIDINONA O UNA IMIDAZOLIDINONA; REDUCIR; CONVERTIR EL PRODUCTO EN UNA AZIDA Y LUEGO A UNA SAL DE AMINA; REDUCIR DICHA SAL DE AMINA A UNA SAL DE AMINO ALCOHOL DE ESTRUCTURA (II) Y HACERLA REACCIONAR CON R2SO2LG, SIENDO LG UN GRUPO SALIENTE TAL COMO Cl, Br O SULFONATO. UN COMPUESTO PREFERIDO PREPARADO MEDIANTE EL PRESENTE METODO ES [(1S,2R)-2-(3,5-DIFLUOR-FENIL)-3,3,3-TRIFLUOR-1-HIDROXIMETIL-PROPIL]-AMIDA DE ACIDO 5-CLORO-TIOFEN-2-SULFONICO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95965907P | 2007-07-16 | 2007-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20090824A1 true PE20090824A1 (es) | 2009-07-24 |
Family
ID=40260327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008001177A PE20090824A1 (es) | 2007-07-16 | 2008-07-14 | Proceso para la preparacion de trifluoralquil-fenil sulfonamidas y de sulfonamidas heterociclicas |
Country Status (7)
Country | Link |
---|---|
US (1) | US20090023903A1 (es) |
AR (1) | AR067534A1 (es) |
CL (1) | CL2008002058A1 (es) |
PA (1) | PA8789601A1 (es) |
PE (1) | PE20090824A1 (es) |
TW (1) | TW200911778A (es) |
WO (1) | WO2009012201A2 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2004000647A1 (es) * | 2003-03-31 | 2005-02-04 | Wyeth Corp | Compuestos derivados de heterociclicos de sulfonamida que contienen fluoro y trifluoro alquilo; composicion farmaceutica; kit farmaceutico; procedimiento de preparacion; y su uso como inhibidores de beta amiloides para tratar alzheimer, angiopatia am |
US9223217B2 (en) * | 2010-02-19 | 2015-12-29 | International Business Machines Corporation | Sulfonamide-containing topcoat and photoresist additive compositions and methods of use |
US9223209B2 (en) * | 2010-02-19 | 2015-12-29 | International Business Machines Corporation | Sulfonamide-containing photoresist compositions and methods of use |
CN102964233A (zh) * | 2012-11-18 | 2013-03-13 | 大连九信生物化工科技有限公司 | 一种3,5-二氟三氟甲基苯酮的合成方法 |
CN103214413B (zh) * | 2013-03-22 | 2015-05-13 | 郑州泰基鸿诺药物科技有限公司 | 一种含杂环的三氟甲基酮化合物及其制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2703802A (en) * | 1953-08-20 | 1955-03-08 | Dow Chemical Co | 4-(trifluoroacetyl) morpholine |
US5461162A (en) * | 1994-07-27 | 1995-10-24 | Merck & Co., Inc. | Process of synthesizing n-acyl auxiliaries |
US5594134A (en) * | 1995-03-31 | 1997-01-14 | Merck & Co., Inc. | Process of synthesizing N-acyl auxiliaries |
SI1341779T1 (sl) * | 2000-12-13 | 2006-12-31 | Wyeth Corp | Heterociklicni sulfonamidni inhibitorji produkcije beta amiloida |
IL165265A0 (en) * | 2002-06-11 | 2005-12-18 | Wyeth Corp | Substituted phenylsulfonamide inhibitors of beta amyloid production |
CL2004000647A1 (es) * | 2003-03-31 | 2005-02-04 | Wyeth Corp | Compuestos derivados de heterociclicos de sulfonamida que contienen fluoro y trifluoro alquilo; composicion farmaceutica; kit farmaceutico; procedimiento de preparacion; y su uso como inhibidores de beta amiloides para tratar alzheimer, angiopatia am |
JP2007517905A (ja) * | 2004-01-16 | 2007-07-05 | ワイス | アゾールを含有するベータアミロイド産生のヘテロ環式スルホンアミド阻害剤 |
RU2008129797A (ru) * | 2006-02-17 | 2010-03-27 | Вайет (Us) | Способы получения сульфонамид-замещенных спиртов и их промежуточных соединений |
RU2008131051A (ru) * | 2006-02-17 | 2010-03-27 | Вайет (Us) | Избирательное n-сульфонилирование 2-амино трифторалкильнзамещенных спиртов |
US7476762B2 (en) * | 2006-04-21 | 2009-01-13 | Wyeth | Methods for preparing sulfonamide compounds |
US7550629B2 (en) * | 2006-04-21 | 2009-06-23 | Wyeth | Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors |
-
2008
- 2008-07-14 US US12/172,486 patent/US20090023903A1/en not_active Abandoned
- 2008-07-14 TW TW097126639A patent/TW200911778A/zh unknown
- 2008-07-14 WO PCT/US2008/069934 patent/WO2009012201A2/en active Application Filing
- 2008-07-14 PA PA20088789601A patent/PA8789601A1/es unknown
- 2008-07-14 PE PE2008001177A patent/PE20090824A1/es not_active Application Discontinuation
- 2008-07-14 AR ARP080103020A patent/AR067534A1/es unknown
- 2008-07-14 CL CL2008002058A patent/CL2008002058A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CL2008002058A1 (es) | 2008-11-14 |
PA8789601A1 (es) | 2009-02-09 |
WO2009012201A2 (en) | 2009-01-22 |
TW200911778A (en) | 2009-03-16 |
AR067534A1 (es) | 2009-10-14 |
WO2009012201A3 (en) | 2009-07-02 |
US20090023903A1 (en) | 2009-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0516911A (pt) | método para a preparação de um composto e composto de anilina | |
RU2010126906A (ru) | Способ получения производного индолинона | |
PE20090824A1 (es) | Proceso para la preparacion de trifluoralquil-fenil sulfonamidas y de sulfonamidas heterociclicas | |
BR112013004827A2 (pt) | "processo para a produção de derivados de 1-triazol-2-butanol" | |
AR055779A1 (es) | Proceso de preparacion de azoxistrobina y composicion que contiene al compuesto | |
DE602006008962D1 (de) | Verfahren zur herstellung von valsartan | |
RU2013112946A (ru) | Способ получения промежуточных соединений для получения ингибиторов nep | |
AR083213A1 (es) | Proceso de preparacion de derivados pirimidinicos, compuestos intermediarios y proceso para prepararlos | |
RU2009117654A (ru) | Получение азоксистробина | |
GB201007756D0 (en) | Composition, method and use | |
RU2011139325A (ru) | Аморфная соль макроциклического ингибитора hcv | |
CO6300859A2 (es) | Metodos para inhibidir las respuestas del etileno en plantas usando compuestos de cilpropeno amina | |
EA200701470A1 (ru) | Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений | |
MX2009003257A (es) | Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina. | |
BR112015001769A2 (pt) | Processo para a síntese de compostos de ureia substituída | |
RU2011108663A (ru) | Способы получения метилового эфира 4-оксооктагидроиндол-1-карбоновой кислоты и ее производные | |
RU2012128887A (ru) | Способ получения гидрохлорида моксифлоксацина и его промежуточных продуктов | |
MY134924A (en) | Process for the industrial synthesis of tetraesters of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates | |
EA200900008A1 (ru) | Новые хиральные промежуточные продукты, способ их получения и их применение в производстве толтеродина, фезотеродина или их активных метаболитов | |
ATE529413T1 (de) | Verfahren zur synthese von aryloxydiaminopyrimidinen | |
AR051936A1 (es) | Proceso para la preparacion de pirazoles | |
EA201071001A1 (ru) | Способ получения комбретастатина | |
RU2014111810A (ru) | Кристалл 5-гидрокси-1н-имидазол-4-карбоксамид˙3/4 гидрата, способ его получения и кристалл 5-гидрокси-1н-имидазол-4-карбоксамида гидрата | |
ES2532903T3 (es) | Métodos y compuestos para la preparación de compuestos orgánicos biológicamente activos monofluorometilados | |
BRPI0808570B8 (pt) | processo para a preparação de inibidores de glyt-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FX | Voluntary withdrawal |